News

Click here to answer this week's poll.

AAD vice president challenges dermatologists to advocate for their patients and themselves.

Resident billing can have huge financial implications on academic institutions. A poster from the Icahn School of Medicine at Mount Sinai aimed to assess new medical coding lectures and a modified note template at Winter Clinical Dermatology Conference.

ICYMI, this week we had stories on Vial's CRO launch, our conference coverage coming up this weekend, and more.

Several talks expected to focus on the latest treatment updates, as well as some recently published data on COVID-19 symptoms and a commonly-used atopic dermatitis treatment.

Energy and autos lead the way, health care relatively stable

Vial launches Vial Dermatology contract research organization (CRO) and highlights how it could improve the speed and quality of clinical trials.

In this month's Cosmetic Conundrums, Zoe Diana Draelos, MD, an adjunct assistant professor of dermatology at Duke University School of Medicine in Durham, North Carolina, and chief medical editor of Dermatology Times®, tackles cosmetic box claims and what exactly 'sensitive skin' means in the cosmetic world.

A national survey found that patients are willing to try medical cannabis products as potential treatments of their condition. Additionally, some already use over-the-counter cannabis products.

Lubriderm and the National Hispanic Health Foundation collaborate on the Skin Scholarship sponsored by Lubriderm to help increase United States Hispanic representation and accessibility in dermatology.

The new year promises to be rich with dermatology game changers following a sluggish 2021 for breakthroughs and FDA approvals.

This week's edition of the Mainstream Patients features stories about at-home microdermabrasion, the science of oily hair, and more.

Click to see a preview of what to expect this week.

ICYMI, this week we had stories on the continued issues with iPLEDGE, the new data on spesolimab treatment for GPP, and more.

The Skin of Color Society released an article detailing its 2021 achievements, containing what the society considers its most active and successful year.

FUE is a type of hair transplant that requires physicians to change tools to accommodate different hair and scalp types. Now, a recent study highlights a single device aiming to treat all types of hair situations.

But mask-wearing still vital to slowing spread of disease, agency says.

This week's edition of the Mainstream Patients features stories about rosemary oil for hair, Ava Max dealing with Covid-19 hair loss, and more.

Click to see a preview of what to expect this week.

ICYMI, some of this week’s featured content includes an exclusive interview about lasers and acne, and articles on 2021's top 20 stories, the declining preference for telehealth, and more.

Each month, Dermatology Times® features a roundup of products trending in skin care. Click here to find out what products are trending for the month of December

Dermatology Times® broke the news that the carcinogen benzene was found in multiple sunscreens, but that wasn’t the only major headline of the year. We revisit the 20 stories of 2021 that made the greatest impact.

Two possible explanations for declining contentment with live video calls as a form of care delivery.

A recent study investigates the probability of BDD in cosmetic dermatology with the help of a new screening tool.

This week's edition of the Mainstream Patients features stories about the best hair removal methods, pH levels in the skin, and more.

Click to see a preview of what to expect this week.

Don't Forget to take this week's poll.

ICYMI, some of this week’s featured content includes an exclusive interview about the occupational dermatoses, and articles on 2021's breakthroughs and disappointments, the risk of psoriasis related to BMI and more.

The past year gave dermatologists ample cause for both celebration and frustration as they looked forward to new drugs, devices, and technology to optimize patient care. Here, Dermatology Times® editorial advisory board members weigh in on the good, bad, and still-TBD changes that shaped the specialty during 2021.